Selected other transactions

Strategic Capital

CapVest (2020)

  • Acquisition of Curium by a CapVest-managed Continuation Fund from CapVest Equity Partners III
  • Provided financial, debt and hedging advice and a fairness opinion to the Continuation Fund
  • Builds upon our long standing relationship with CapVest and Curium, having advised on the disposal of IBA Molecular to CapVest in 2015, followed by advising CapVest and Curium on the acquisition of Cyclopharma in 2018

Equity Advisory

MLPCare (2018)

  • Adviser to MLPCare on its c.TL1.4bn (c.$367m) IPO
  • Independently advised on the initial price range setting, the restructured price range and the final IPO price
  • Closely supervised the bookbuilding process, and provided tactical advice on messaging to investors to help ensure the restructured deal would be a success

Debt Advisory

Montreux (2021)

  • Adviser to Montreux Capital Management and Active Care Group on its £192m refinancing
  • Rothschild & Co worked closely with Management to build and present a compelling credit story, leveraging the deal team’s deep understanding of the business and broader sector
  • Proceeds enabled the group to finance the recapitalisation of the business as well as establishing significant committed acquisition facilities